Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PACTR201403000667409Not yet recruiting
Open-label trial of calcium hydroxide in pulpal necrosis (2 arms), sponsored by sherif el shershaby. Primary endpoint: postoperative pain. Planned start Sep 2014; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on PACTR201403000667409.